Human TSLP polynucleotides
US7405058B2 · kind B2 · utility
8Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2006 |
| Grant date | Jul 29, 2008 |
| Priority date | — |
| Expiry date | Jun 13, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.